Farther Finance Advisors »

Mineralys Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Mineralys Therapeutics

Jan 2024Mar 2024May 2024Jul 2024Sep 2024Nov 2024Jan 20251401601802002201616.51717.518
Value ($)Share countHistorical MLYS position of Farther Finance Advisors Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $208 17 12.29
2024-09-30 $205 17 12.12
2024-06-30 $207 17 12.18
2024-03-31 $221 17 13.06
2023-12-31 $145 17 8.59

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Apple Stock (AAPL)
Microsoft Corp Stock (MSFT)
Ishares National Muni Bond Etf Etf (MUB)
Nvidia Corporation Stock (NVDA)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Amazon Stock (AMZN)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares Core S&p Small Cap Etf Etf (IJR)

View all positions for Farther Finance Advisors

Top funds holding Mineralys Therapeutics

Catalys Pacific
Samsara BioCapital
RA Capital Management
TCG Crossover Management
BlackRock
Sr One Capital Management
Franklin Resources
OrbiMed Advisors
Vanguard Group
Laurion Capital Management
Adams Street Partners
Millennium Management
Jennison Associates
Caligan Partners
Integral Health Asset Management

View all funds holding Mineralys Therapeutics